Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with M
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q2 2024 | METHYLCELLULOSE | OPHTHALMIC | SOLUTION/ DROPS | 0.50 %w/v | Deletion | ||
| Q1 2024 | METHYLCELLULOSE | OPHTHALMIC | SUSPENSION | 0.05 %w/w | MDE Replacement | ||
| Q2 2024 | METHYLCELLULOSE | OPHTHALMIC | SUSPENSION | 1mg | MDE Replacement | ||
| Q1 2024 | METHYLPARABEN | ORAL | GRANULE, FOR SUSPENSION | 8.00 mg/ 5.00 ml | MDE Replacement | ||
| Q2 2024 | METHYLPARABEN | ORAL | GRANULE, FOR SUSPENSION | 80mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: March 15, 2024
Database Last Updated: April 29, 2024